| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2660-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34884-10ug | |||
| Carrier-Free | NBP2-34884-1mg | |||
| Carrier-Free | NBP2-34884-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34924-10ug | |||
| Carrier-Free | NBP2-34924-1mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34911-1mg | |||
| Carrier-Free | NBP2-34911-100ug | |||
| Carrier-Free | NBP2-34911-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35149-10ug | |||
| Carrier-Free | NBP2-35149-1000ug | |||
| Carrier-Free | NBP2-35149-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35171-1mg | |||
| Carrier-Free | NBP2-35171-100ug | |||
| Carrier-Free | NBP2-35171-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35036-1mg | |||
| Carrier-Free | NBP2-35036-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35061-10ug | |||
| Carrier-Free | NBP2-35061-1mg | |||
| Carrier-Free | NBP2-35061-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52687-0.025mg | |||
![Sandwich ELISA: LIS1 Antibody (2C12) [H00005048-M01] - Detection limit for recombinant GST tagged PAFAH1B1 is approximately 0.03ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/LIS1-Antibody-2C12-Sandwich-ELISA-H00005048-M01-img0002.jpg "Sandwich ELISA: LIS1 Antibody (2C12) [H00005048-M01] - Detection limit for recombinant GST tagged PAFAH1B1 is approximately 0.03ng/ml as a capture antibody.")
![ELISA: ARHGEF1 Antibody (1H4) [H00009138-M01] - Detection limit for recombinant GST tagged ARHGEF1 is approximately 3ng/ml as a capture antibody.](http://images.novusbio.com/fullsize/ARHGEF1-Antibody-1H4-ELISA-H00009138-M01-img0003.jpg "ELISA: ARHGEF1 Antibody (1H4) [H00009138-M01] - Detection limit for recombinant GST tagged ARHGEF1 is approximately 3ng/ml as a capture antibody.")
![SDS-Page: Human G-CSF Protein [NBP2-34884]](http://images.novusbio.com/fullsize/Human-G-CSF-Protein-SDS-Page-NBP2-34884-img0001.jpg "SDS-Page: Human G-CSF Protein [NBP2-34884]")
![SDS-Page: Human KGF/FGF-7 Protein [NBP2-34924]](http://images.novusbio.com/fullsize/Human-KGF-FGF-7-Protein-SDS-Page-NBP2-34924-img0002.jpg "SDS-Page: Human KGF/FGF-7 Protein [NBP2-34924]")
![SDS-Page: Human CXCL10/IP-10/CRG-2 Protein [NBP2-34911]](http://images.novusbio.com/fullsize/Human-CXCL10-IP-10-CRG-2-Protein-SDS-Page-NBP2-34911-img0001.jpg "SDS-Page: Human CXCL10/IP-10/CRG-2 Protein [NBP2-34911]")
![SDS-Page: Mouse Midkine Protein [NBP2-35171]](http://images.novusbio.com/fullsize/Mouse-Midkine-Protein-SDS-Page-NBP2-35171-img0001.jpg "SDS-Page: Mouse Midkine Protein [NBP2-35171]")
![SDS-Page: Mouse FGF-9 Protein [NBP2-35036]](http://images.novusbio.com/fullsize/Mouse-FGF-9-Protein-SDS-Page-NBP2-35036-img0001.jpg "SDS-Page: Mouse FGF-9 Protein [NBP2-35036]")
![SDS-Page: Mouse G-CSF Protein [NBP2-35061]](http://images.novusbio.com/fullsize/Mouse-G-CSF-Protein-SDS-Page-NBP2-35061-img0001.jpg "SDS-Page: Mouse G-CSF Protein [NBP2-35061]")
![Flow Cytometry: OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) - Chimeric [NBP2-52687] - Human peripheral blood leukocytes were fixed using 2% PFA, permeabilised using 0.5% Triton and stained with unimmunized rabbit IgG antibody (isotype control, black line) or the rabbit IgG-chimeric version of R4930 (NBP2-52687, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/OX40-Ligand-TNFSF4-Antibody-R4930-Oxelumab-Chimeric-Flow-Cytometry-NBP2-52687-img0001.jpg "Flow Cytometry: OX40 Ligand/TNFSF4 Antibody (R4930 (Oxelumab)) - Chimeric [NBP2-52687] - Human peripheral blood leukocytes were fixed using 2% PFA, permeabilised using 0.5% Triton and stained with unimmunized rabbit IgG antibody (isotype control, black line) or the rabbit IgG-chimeric version of R4930 (NBP2-52687, blue line) at a dilution of 1:100 for 1h at RT. After washing, bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.")
![Western Blot: MAPRE1 Antibody (C8) [NBP3-41844] - Sample: Lane1: Hela cell lysate; Lane2: Jurkat cell lysate; Lane3: A431 cell lysate Primary Ab: 3ug/ml NBP3-41844; Second Ab: 0.2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody](http://images.novusbio.com/fullsize/nbp3-41844_mouse-mapre1-mab-c8-612202421262958.jpg "Western Blot: MAPRE1 Antibody (C8) [NBP3-41844] - Sample: Lane1: Hela cell lysate; Lane2: Jurkat cell lysate; Lane3: A431 cell lysate Primary Ab: 3ug/ml NBP3-41844; Second Ab: 0.2ug/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody")